Skip to main content

Table 1 Receptor-Ligand docking results with Glide XP score, H-bonds and MMGBSA

From: Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties

Compounds

XP Glide score kcal/mol

XH-bond

Interactions

MMGBSA score kcal/mol

Donor

Acceptor

Rosiglitazone (BRL)

−6.833

Hie449:NH

BRL: O

−105.038

Tyr473:OH

BRL:HN

Ser289:OH

BRL: O

Hie323:NH

BRL: O

Resolvin E1 (RsvE1)

−9.900

Hie449:NH

REV1: O

−106.046

Tyr327:HO

REV1: HO

Glu291: O

REV1: HO

Neuroprotectin D1 (NPD1)

−9.664

Ser289:OH

NPD1: O

−102.57

Ser289:OH

NPD1: OH

Hydroxy-linoleic acid (H-LA)

−6.235

Tyr473:OH

HLA:HO

−95.027

Ser289:OH

HLA: O

Docosahexaenoic acid (DHA)

−7.925

Hie323:NH

AA: O

−89.785

Lipoxin A4 (LXA4)

−5.796

Tyr327:OH

LXA4: HO

−87.547

Hie449:NH

LXA4: O

Gamma-linoleic acid (GLA)

−5.068

Hie323:NH

GLA: O

−77.117

Ser289:OH

GLA: O

Arachidonic acid (AA)

−7.040

Hie323:NH

AA: O

−76.586

Alpha-linoleic acid (AL)

−5.174

Hie449:NH

AL: O

−73.657

Eicosapentaenoic acid (EPA)

−7.126

Hie323:NH

EPA: O

−71.147

Ser289:OH

EPA: O

Linoleic acid (LA)

−4.820

Glu343:NH

LA: O

−78.026

  1. Compounds are ranked collectively based on XP glide score and MMGBSA score showing significance with reference ligand rosiglitazone (RsvE1 > NPD1 > HLA > DHA > LXA4 > GLA > AA > ALA > EPA > LA)